Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
David D. DavidarDirector | Globus MedicalGMED | Open-market sale | 06/05 | 06/09 | 25,000 sh | $80.76 | $2,019,000 | −4.7% |
Kelly HullerEVP, GC, Corporate Secretary | Globus MedicalGMED | Open-market sale10b5-1 plan | 02/25 | 02/27 | 20,000 sh | $94.50 | $1,890,000 | −100.0% |
Kelly HullerEVP, GC, Corporate Secretary | Globus MedicalGMED | Open-market sale10b5-1 plan | 02/12 | 02/17 | 10,000 sh | $87.67 | $876,700 | −100.0% |
Leslie V. NorwalkDirector | Globus MedicalGMED | Open-market sale10b5-1 plan | 01/08 | 01/12 | 2,000 sh | $101.10 | $202,200 | −16.1% |
Kyle KlineSVP, CFO | Globus MedicalGMED | Open-market sale10b5-1 plan | 01/08 | 01/12 | 3,594 sh | $101.10 | $363,353.4 | −100.0% |
Leslie V. NorwalkDirector | Globus MedicalGMED | Open-market sale10b5-1 plan | 25/12/12 | 25/12/16 | 4,000 sh | $88.85 | $355,400 | −24.4% |
Kyle KlineSVP, CFO | Globus MedicalGMED | Open-market sale10b5-1 plan | 25/12/01 | 25/12/03 | 18,542 sh | $90.00 | $1,668,780 | −100.0% |
Kelly HullerSVP, GC, Corporate Secretary | Globus MedicalGMED | Open-market sale10b5-1 plan | 25/11/25 | 25/11/28 | 7,500 sh | $90.00 | $675,000 | −100.0% |
David D. DavidarDirector | Globus MedicalGMED | Open-market sale | 25/11/12 | 25/11/13 | 25,000 sh | $86.00 | $2,150,000 | −4.6% |
Stephen T. ZarrilliDirector | Globus MedicalGMED | Open-market sale | 25/11/11 | 25/11/13 | 25,000 sh | $84.29 | $2,107,250 | −100.0% |
Globus MedicalGMED | Open-market sale10b5-1 plan | 25/11/07–25/11/10 | 25/11/10 | 10,000 sh2 trades | $81.80avg. | $818,000 | −39.4% | |
Rhoads Ann D.Director | Globus MedicalGMED | Open-market sale10b5-1 plan | 25/09/15 | 25/09/16 | 10,000 sh | $58.46 | $584,600 | −28.3% |
Rhoads Ann D.Director | Globus MedicalGMED | Open-market sale10b5-1 plan | 25/02/28 | 25/03/04 | 7,500 sh | $78.68 | $590,100 | −17.5% |
Globus MedicalGMED | Open-market sale10b5-1 plan | 25/01/10 | 25/01/14 | 14,167 sh2 trades | $88.29avg. | $1,250,770.39 | −100.0% | |
Kelly HullerSVP, GC, Corporate Secretary | Globus MedicalGMED | Open-market sale10b5-1 plan | 24/12/02 | 24/12/04 | 2,500 sh | $87.00 | $217,500 | −100.0% |
Globus MedicalGMED | Open-market sale | 24/11/21–24/11/22 | 24/11/25 | 14,375 sh2 trades | $85.00avg. | $1,221,896.94 | −100.0% | |
Globus MedicalGMED | Open-market sale10b5-1 plan | 24/11/21–24/11/22 | 24/11/25 | 40,000 sh4 trades | $85.00avg. | $3,400,000 | No record | |
Daniel T. ScavillaPresident, CEO | Globus MedicalGMED | Open-market sale10b5-1 plan | 24/11/21 | 24/11/25 | 130,000 sh | $85.00 | $11,050,000 | −100.0% |
Daniel T. ScavillaPresident, CEO | Globus MedicalGMED | Open-market sale10b5-1 plan | 24/11/06 | 24/11/08 | 60,000 sh | $80.02 | $4,801,200 | −100.0% |
Globus MedicalGMED | Open-market sale10b5-1 plan | 24/11/06 | 24/11/08 | 5,000 sh2 trades | $81.01avg. | $405,050 | −100.0% |